| Year |
Citation |
Score |
| 2018 |
Zachry W, Halajko D, Hayes V, Neff G. Cost Benefit and Break-Even Analysis of Screening for Non-Alcoholic Fatty Liver Disease Utilizing FibroScan as Compared to Usual Care: 1011 The American Journal of Gastroenterology. 113. DOI: 10.14309/00000434-201810001-01011 |
0.329 |
|
| 2010 |
Lang K, Korn JR, Simko RJ, Zachry WM, Patel NV, Nair R, Menzin J. Development of an interactive model of the burden of future coronary heart disease from an employer perspective. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 52: 851-7. PMID 20798652 DOI: 10.1097/JOM.0b013e3181ebbb3d |
0.47 |
|
| 2009 |
Zachry WM, Doan QD, Smith BJ, Clewell JD, Griffith JM. Direct medical costs for patients seeking emergency care for losses of epilepsy control in a U.S. managed care setting. Epilepsy & Behavior : E&B. 16: 268-73. PMID 19747882 DOI: 10.1016/j.yebeh.2009.07.042 |
0.605 |
|
| 2009 |
Brown CM, Nwokeji E, Rascati KL, Zachry W, Phillips GA. Development of the burden of prior authorization of psychotherapeutics (BoPAP) scale to assess the effects of prior authorization among Texas Medicaid providers. Administration and Policy in Mental Health. 36: 278-87. PMID 19350379 DOI: 10.1007/S10488-009-0220-4 |
0.382 |
|
| 2009 |
Zachry WM, Doan QD, Clewell JD, Smith BJ. Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes. Epilepsia. 50: 493-500. PMID 18616554 DOI: 10.1111/j.1528-1167.2008.01703.x |
0.601 |
|
| 2008 |
Brown CM, Richards K, Rascati KL, Gavaza P, Corbell Z, Zachry W, Phillips GA. Effects of a psychotherapeutic drug prior authorization (PA) requirement on patients and providers: a providers' perspective. Administration and Policy in Mental Health. 35: 181-8. PMID 18064560 DOI: 10.1007/S10488-007-0158-3 |
0.381 |
|
| 2004 |
Abarca J, Malone DC, Armstrong EP, Zachry WM. Angiotensin-converting enzyme inhibitor therapy in patients with heart failure enrolled in a managed care organization: effect on costs and probability of hospitalization. Pharmacotherapy. 24: 351-7. PMID 15040648 DOI: 10.1592/Phco.24.4.351.33175 |
0.381 |
|
| 2003 |
Zachry WM, Dalen JE, Jackson TR. Clinicians' responses to direct-to-consumer advertising of prescription medications. Archives of Internal Medicine. 163: 1808-12. PMID 12912716 DOI: 10.1001/Archinte.163.15.1808 |
0.33 |
|
| 2003 |
Vogel RJ, Ramachandran S, Zachry WM. A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals. Clinical Therapeutics. 25: 309-29. PMID 12637129 DOI: 10.1016/S0149-2918(03)90043-9 |
0.309 |
|
| 2003 |
Zachry WM. Analysis of the Relationship of Direct-to-Consumer Advertising and Patients Seeking Ambulatory Care Journal of Pharmaceutical Marketing & Management. 15: 45-59. DOI: 10.1300/J058V15N03_05 |
0.367 |
|
| 2003 |
Armstrong ER, Goodman NM, Zachry WM. Community Pharmacists' Opinions about Having Diagnostic Data Provided with Prescriptions Journal of Pharmacy Practice. 16: 361-365. DOI: 10.1177/0897190003259715 |
0.364 |
|
| 2002 |
Zachry WM, Armstrong EP. Health care professionals' perceptions of the role of pharmacogenomic data. Journal of Managed Care Pharmacy : Jmcp. 8: 278-84. PMID 14613421 DOI: 10.18553/Jmcp.2002.8.4.278 |
0.339 |
|
| 2002 |
Zachry WM, Shepherd MD, Hinich MJ, Wilson JP, Brown CM, Lawson KA. Relationship between direct-to-consumer advertising and physician diagnosing and prescribing. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 59: 42-9. PMID 11813466 DOI: 10.1093/Ajhp/59.1.42 |
0.604 |
|
| 2001 |
Zachry WM, Ginsburg DB. Patient autonomy and the regulation of direct-to-consumer advertising. Clinical Therapeutics. 23: 2024-2037. PMID 11813936 DOI: 10.1016/S0149-2918(01)80155-7 |
0.314 |
|
| 2001 |
Zachry WM, Shepherd MD, Wilson JP. Inpatient utilization of medical services associated with peripheral arterial disease-related inpatient procedures in the Department of Defense. Vascular Medicine (London, England). 6: 71-6. PMID 11530967 DOI: 10.1177/1358836X0100600201 |
0.575 |
|
| Show low-probability matches. |